COMPANY OVERVIEW

Xynomic Pharmaceuticals, Inc. is a US emerging biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xymonic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world.

---

LOCATION

Dover, DE, USA

Shanghai, , China

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://xynomicpharma.com/en/506-11/

---

CAREER WEBSITE

https://xynomicpharma.com/jobs/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Sep 23, 2019

Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma

Sep 23, 2019

Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma

Sep 23, 2019

Xynomic Pharma Receives Important Accreditation from Independent Ethics Committees of Leading Chinese Cancer Hospitals

Sep 20, 2019

Delisting of Securities of Hunter Maritime Acquisition Corp., ADOMANI, Inc., Xynomic Pharmaceuticals Holdings, Inc., China TechFaith Wireless Communication Technology Limited, and Warrant of Allied Esports Entertainment, Inc. from The Nasdaq Stock Market

Sep 13, 2019

Xynomic Pharma Doses First Chinese Patient in Pivotal Phase 3 Kidney Cancer Trial and Hires Medical Monitor

For More Press Releases

---